Specifically, an overactive bladder is seen even in the early stages of PD3 and one study has reported that istradefylline, an adenosine A2A receptor antagonist, can effectively improve not only motor symptoms but also LUTS in patients with PD in clinical settings4. Here, ADORA2A is linked to Parkinson disease.